HCA Healthcare, Inc. (HCA) fair value analysis

S&P 500 · Updated 2026-09-07

HCA Healthcare, Inc. operates one of the largest networks of hospitals and healthcare facilities in the United States, providing a wide range of medical services including emergency care, surgery, diagnostics, and specialty treatments. The company operates hospitals and healthcare facilities across numerous states throughout the country, serving patients in both urban and rural communities.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, HCA is trading at a 10–25% discount to estimated fair value.

HCA currently ranks #52 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 2 consecutive weekly runs.

Last price: $405.00
Sector: Healthcare
12-month range: $370.96–$532.92

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: C
Leverage: Low
Margin trend: Stable
Revenue growth: Modest
RSI zone: Neutral
52-week position: The bottom quarter of its range
DCF cross-check: Fairly Valued

What our data shows for HCA

Our model validated 17 trailing price-to-earnings windows for HCA, built from quarterly earnings records.
Shares are trading in the lower third of their 12-month price range of $370.96–$532.92.
The 14-day relative strength index sits at a neutral 44.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for HCA
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent HCA news

TickrTrends' derived news-sentiment signal for HCA is currently leaning positive, computed from recent coverage.

Is HCA Healthcare Stock Underperforming the Nasdaq? (finance.yahoo.com, 2026-09-03)
TickrTrends take: HCA Healthcare operates in the Healthcare sector where valuation metrics can vary significantly based on operational performance and market conditions. Given TickrTrends' current assessment that HCA is undervalued, investors focused on valuation should monitor whether recent underperformance relative to the Nasdaq reflects temporary market dynamics or fundamental changes in the company's earning power and competitive position. The divergence between HCA's stock movement and broader market indices warrants attention to underlying business metrics and whether the current valuation represents a meaningful opportunity or signals deeper concerns about sector-specific headwinds.
HCA Healthcare (HCA) Navigates Patient Volume Challenges While Reporting Growth (finance.yahoo.com, 2026-09-01)
TickrTrends take: HCA Healthcare faces patient volume headwinds even as it reports overall growth, a dynamic that investors tracking valuation should monitor closely since revenue per patient and occupancy rates directly impact margin sustainability. TickrTrends currently assesses HCA as undervalued relative to its fundamentals, though the patient volume challenge suggests near-term operational pressures that could influence how that valuation gap evolves. A valuation-focused reader should track whether management can offset volume declines through pricing actions or operational efficiency gains, as these levers will be critical to defending current profitability levels.

What people are saying

Follow the HCA conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — HCA's valuation indicators shifted this week as the DCF cross-check band moved from overvalued to fairly valued, which aligns with the current undervalued verdict from TickrTrends' derived indicators. This adjustment reflects a narrowing of the valuation range and suggests improving alignment between different valuation methodologies for the healthcare company.
2026-09-06 — HCA's position within the Healthcare sector has improved this week, with its sector discount rank rising from #57 to #52, indicating stronger relative value compared to peer companies. The valuation verdict has shifted from Fairly valued to Undervalued, reflecting a more attractive pricing environment for the stock within its sector.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is HCA stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), HCA is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is HCA's TickrTrends verdict?

HCA's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does HCA compare to other Healthcare stocks?

HCA ranks #52 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is HCA overbought or oversold?

HCA's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

HCA vs BDX · HCA vs ENSG · HCA vs EW · HCA vs GMAB · HCA vs MTD